206 related articles for article (PubMed ID: 18533277)
1. PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis.
Lefvert AK; Zhao Y; Ramanujam R; Yu S; Pirskanen R; Hammarström L
J Neuroimmunol; 2008 Jul; 197(2):110-3. PubMed ID: 18533277
[TBL] [Abstract][Full Text] [Related]
2. Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis.
Vandiedonck C; Capdevielle C; Giraud M; Krumeich S; Jais JP; Eymard B; Tranchant C; Gajdos P; Garchon HJ
Ann Neurol; 2006 Feb; 59(2):404-7. PubMed ID: 16437561
[TBL] [Abstract][Full Text] [Related]
3. The autoimmunity-related polymorphism PTPN22 1858C/T is associated with anti-titin antibody-positive myasthenia gravis.
Greve B; Hoffmann P; Illes Z; Rozsa C; Berger K; Weissert R; Melms A
Hum Immunol; 2009 Jul; 70(7):540-2. PubMed ID: 19406179
[TBL] [Abstract][Full Text] [Related]
4. Effects of FK506 on myasthenia gravis patients with high interleukin-2 productivity in peripheral blood mononuclear cells.
Utsugisawa K; Nagane Y; Yonezawa H; Obara D; Kondoh R; Tohgi H
Muscle Nerve; 2003 Feb; 27(2):245-8. PubMed ID: 12548534
[TBL] [Abstract][Full Text] [Related]
5. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
Zhang J; Zhou WB; Wang HL; Guo SS
Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
[TBL] [Abstract][Full Text] [Related]
6. [In vitro immunoglobulin synthesis by peripheral blood mononuclear cells from patients with myasthenia gravis].
Miyazaki Y; Arikawa E; Kubota H; Yagi K; Tanabe H
Rinsho Shinkeigaku; 1990 Jan; 30(1):1-6. PubMed ID: 2331813
[TBL] [Abstract][Full Text] [Related]
7. High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis.
Yapici Z; Tüzün E; Altunayoğlu V; Erdoğan A; Eraksoy M
Int J Neurosci; 2007 Nov; 117(11):1505-12. PubMed ID: 17917921
[TBL] [Abstract][Full Text] [Related]
8. The association of PTPN22 R620W polymorphism is stronger with late-onset AChR-myasthenia gravis in Turkey.
Kaya GA; Coşkun AN; Yılmaz V; Oflazer P; Gülsen-Parman Y; Aysal F; Disci R; Direskeneli H; Marx A; Deymeer F; Saruhan-Direskeneli G
PLoS One; 2014; 9(8):e104760. PubMed ID: 25119822
[TBL] [Abstract][Full Text] [Related]
9. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries.
Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I
Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546
[TBL] [Abstract][Full Text] [Related]
11. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population.
Chabchoub G; Teixiera EP; Maalej A; Ben Hamad M; Bahloul Z; Cornelis F; Ayadi H
Ann Hum Biol; 2009; 36(3):342-9. PubMed ID: 19343596
[TBL] [Abstract][Full Text] [Related]
12. [Antibodies in myasthenia gravis].
Eymard B
Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
[TBL] [Abstract][Full Text] [Related]
14. Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor.
Vernet-der Garabedian B; Lacokova M; Eymard B; Morel E; Faltin M; Zajac J; Sadovsky O; Dommergues M; Tripon P; Bach JF
J Clin Invest; 1994 Aug; 94(2):555-9. PubMed ID: 8040310
[TBL] [Abstract][Full Text] [Related]
15. [Anesthetic considerations for thymectomy in a patient having an anti-acetylcholine receptor antibody without myasthenia gravis].
Koshida T; Hara K; Obara G; Sata T
Masui; 2008 Aug; 57(8):993-5. PubMed ID: 18710007
[TBL] [Abstract][Full Text] [Related]
16. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
17. PTPN22 R620W Polymorphism is Associated with Myasthenia Gravis Risk: A Systematic Review and Meta-Analysis.
Xiong X; Xiang M; Cheng X; Huang Y
Med Sci Monit; 2015 Aug; 21():2567-71. PubMed ID: 26318187
[TBL] [Abstract][Full Text] [Related]
18. Frequency of seronegativity in adult-acquired generalized myasthenia gravis.
Chan KH; Lachance DH; Harper CM; Lennon VA
Muscle Nerve; 2007 Nov; 36(5):651-8. PubMed ID: 17654558
[TBL] [Abstract][Full Text] [Related]
19. Myasthenia gravis experimentally induced with muscle-specific kinase.
Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
[TBL] [Abstract][Full Text] [Related]
20. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G
Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
